Tower Research Capital (TRC)’s Neuropace NPCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $30.2K | Buy |
|
|||||
|
2025
Q1 | $9.35K | Sell |
|
|||||
|
2024
Q4 | $12.8K | Sell |
|
|||||
|
2024
Q3 | $8.38K | Sell |
|
|||||
|
2024
Q2 | $33.3K | Buy |
|
|||||
|
2024
Q1 | $49.7K | Buy |
|
|||||
|
2023
Q4 | $2.6K | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $404 | Sell |
|
|||||
|
2023
Q1 | $4K | Sell |
|
|||||
|
2022
Q4 | $9K | Buy |
|
|||||
|
2022
Q3 | $19K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $13K | Buy |
|
|||||
|
2021
Q4 | $11K | Buy |
|
|||||
|
2021
Q3 | $9K | Sell |
|
|||||
|
2021
Q2 | $32K | Buy |
|